MAC Clinical Research is currently conducting a trial to test a new oral medication for eczema. Eczema, or atopic dermatitis, is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 20% of the general population.
Reimbursement: Between £1200 and £1615
Male or female aged 18 – 65.
Diagnosis of eczema for at least the 6 months.
BMI 18 – 35 kg/m2